Abstract
Introduction Dementias and amnesias as the result of neurodegenerative diseases or continious ischemia of brain are now recognised as a major problem and affect a significant proportion of the elderly population. The pharmacological treatment of dementia is directed primaraly at correction of neurotransmitter deficits or enchancement of cerebral metabolic activity, but options are limited at present, because neurochemical pathology of dementias also include a disrupted regulation of neurotransmitter systems-signal transduction mechanism, which depends on cell's membranes conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Phosphorus, Sulfur, and Silicon and the Related Elements
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
